Dinas Kesehatan Kota Padang
Padang, West Sumatra, 25171, Indonesia
NCT Number: NCT04085874
This study aimed to assess effectiveness of promoting the optimized Food-based recommendations (FBRs) for improving dietary practices, nutrient intakes, nutritional status and lipid profile among Minangkabau women of reproductive age with dyslipidemia in a community setting. A cluster randomized community-based trial was conducted in Padang City, West Sumatra, Indonesia. Subjects are Minagabau women of reproductive age (20-44 y) with dyslipidemia. The subjects were assigned either into FBR group (n=48) that involved in 12-weeks prolonged contact of FBRs promotion or into non-FBR group, that received once nutrition counselling from usual standard of nutrition program. Baseline and end-line lipid profiles, nutritional status, dietary practice and nutrient intake data were assessed through biochemical assessment, anthropometri, and interview structured questionaire.
Looking for future studies?
Notify Me20 year–44 year
Female
Interventional
Not applicable
Padang, West Sumatra, 25171, Indonesia
This study was conducted in two sequential phases. The first stage was a formative phase in the form of observational survey to develop and validate food-based recommendations (FBRs). The second phase was an intervention study to assess the effectiveness of the FBRs in improving dietary practice, the intake of problem nutrient, nutritional status and lipid profile of the subject.
Sample size for intervention per group (n=60/group; 2 groups) was expected to detect mean(±SD) differences in LDL-cholesterol concentration (as an secondary outcome) of 14±20 mg/dL as observed in a previous study in other area, with assumption of 80% power and 25% loss of follow up. Potential subjects were identified prior to dyslipidemia screening before intervention. Field nutritionist and volunteer cadres were requested to identify and list women of reproductive age fulfilling the inclusion criteria living in selected sites. An invitation letter was sent to all identified eligible subjects to visit appointed field laboratory to perform blood measurement. Inform consent was signed by all potential participants before blood measurement.
This study did not compare an intervention group (FBR group) with a true control group, but with a comparison group that received once nutrition counselling from usual nutrition health program (non-FBR group). Drawing on concepts of Plan Behavior Theory, persuasive FBR promotion was designed to influence subjects' attitude, subjective norms, perceive behavior control related to dyslipidemia and dietary management, and intention to change. Participants were prompted to set goals for themselves to improve their dietary practices in order to fulfill their nutrient requirements, improve nutritional status and lipid profile.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Prolonged contact through weekly home visits and monthly group meeting for 12 weeks
Other names: Nutrition education
once nutrition counselling from health services
Other names: Standard nutrition care
Time frame: baseline (before the intervention) and end-line (after 12-weeks intervention)
Change in food consumption from baseline at 12-week intervention, evaluated based on participant's compliance to the Optimized Food-Based Recommendations. The compliance were measured using one-week Food Frequency Questionnaire (FFQ), stated in servings/week for staple foods. snacks, animal protein (sea fish, eggs, poultry), soy protein (tofu/tempeh), potato, fruits,dark green vegetables (DGLV), total vegetables and fried foods. The recommendations (servings/week) for those food groups/items was 14-21, 7-14, minimum 5, 3-4, 2-3,minimum 7,minimum 5, minimum 7, minimum 5, minimum 14, and maximum 14 respectively. Those who complied with the recommendations was scored 1 for each recommendations, and 0 for those who did not. The total score for the compliance to the FBRs was 0-11. Higher score represents better participant's compliance
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for energy intake( in Kcal). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for protein intake( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for total fat intake( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for carbohydrate intake ( in gram)
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for PUFA intake ( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for MUFA intake ( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for SFA intake ( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for P/S
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for dietary fiber intake ( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for iron intake ( in mg). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for zinc intake ( in mg). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change in Body weight (in Kg) from baseline at 12-week intervention
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
change of waist circumference (in cm), from baseline at 12-week intervention
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change of total cholesterol (in mg/dL) from baseline at 12-week intervention
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change of LDL (in mg/dL) from baseline at 12-week intervention
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change of HDL (mg/dL) from baseline at 12-week intervention
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change of TG (mg/dL) from baseline at 12-week intervention
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change in body mass index (kg/m2) from baseline at 12-week intervention, calculated from body weight (in kg) divided by square body height (in meter suquare), endline minus baseline
Time frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change of Castelli's index from baseline at 12-week intervention, calculated from the total cholesterol level divided by serum HDL
Politeknik Kesehatan Kemenkes Padang
Other
Effectiveness of Optimized Food-Based Recommendations to Improve Dietary Practice, Intake of Problem Nutrient, Nutritional Status and Lipid Profile Among Minangkabau Women of Reproductive Age With Dyslipidemia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT05394779
Behavior, Behavior, Animal
Milan, Italy
View Trial DetailsNCT05953194
Behavior, Behavior, Animal
Palo Alto, California, United States
View Trial DetailsNCT05776329
Bacteremia, Behavior
Hermosillo, Sonora, Mexico
View Trial Details